Campaign for change: Stop leukaemia devastating lives
Together, we have the power to change lives.
Your voice is powerful
Whether leukaemia has touched your life directly or through someone you love, your experience matters. Leukaemia is distressing—but together, we can help stop it from devastating more lives.
You don’t need to be a policy expert to make a difference. We’ll show you exactly how to turn your voice into action.
Take action. End the delay.
Right now, 1 in 4 people with leukaemia face avoidable delays in diagnosis.
For the first time, leukaemia is recognised in the National Cancer Plan. That recognition matters. But it’s only the first step. Action is what saves lives.
We’re calling on the Government to act. By adding your name, you’ll be supporting the call to deliver early diagnosis for leukaemia, meaning:
• Faster referral for full blood counts when symptoms appear
• Fewer people diagnosed in emergency settings
• Access to specialist haematology care at the right time.
Disclaimer: This work was supported in part with funding from AbbVie, J&J, Novartis and BeOne. These organisations had no input into the development, design, delivery or interpretation of the evidence, and no editorial input into the content presented here.
Stand up for those impacted by leukaemia
Do you believe national policies could do more to save and improve the lives of people with leukaemia?
At Leukaemia UK, we believe they not only can — they must.
We’re tackling real challenges, finding practical solutions, and pushing decision-makers to act.
But we can’t do it alone.
With your support, we can drive the change that’s urgently needed — and we’ll be with you every step of the way.
What we are calling on the government for
Our priorities are shaped by the real experiences of patients, families, and researchers — and they can’t wait.
Why it’s important we continue to push for change
Leukaemia affects over 10,000 people in the UK each year, mostly adults over 65 and it’s also the most common childhood cancer.
37% are diagnosed in emergency settings, reducing treatment options and survival.
Survival rates remain low, especially for acute myeloid leukaemia (AML).
Early diagnosis is critical.
0th
0
0
Behind these numbers are real people, like Jake, whose life have been deeply affected.
Jake’s Story
Jake was only 13 when he caught a cold that he just couldn’t get rid of. It turned out to be the start of three months of strange symptoms, which led to his AML diagnosis. Jake believes the government must do more to help people affected by leukaemia.
